“ Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment ”, Braz. J. Pharm. Sci., vol. 50, no. 2, pp. 345–352, Apr. 2014, doi: 10.1590/S1984-82502014000200014.